202 related articles for article (PubMed ID: 10815895)
1. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
[TBL] [Abstract][Full Text] [Related]
2. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
3. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
[TBL] [Abstract][Full Text] [Related]
4. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
Schmelz K; Wagner M; Dörken B; Tamm I
Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
6. p73, a gene related to p53, is not mutated in esophageal carcinomas.
Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
8. p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.
Nozaki M; Tada M; Kashiwazaki H; Hamou MF; Diserens AC; Shinohe Y; Sawamura Y; Iwasaki Y; de Tribolet N; Hegi ME
Brain Pathol; 2001 Jul; 11(3):296-305. PubMed ID: 11414472
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting and allele switching of p73 in renal cell carcinoma.
Mai M; Qian C; Yokomizo A; Tindall DJ; Bostwick D; Polychronakos C; Smith DI; Liu W
Oncogene; 1998 Oct; 17(13):1739-41. PubMed ID: 9796703
[TBL] [Abstract][Full Text] [Related]
10. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype.
Yokozaki H; Shitara Y; Fujimoto J; Hiyama T; Yasui W; Tahara E
Int J Cancer; 1999 Oct; 83(2):192-6. PubMed ID: 10471526
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K
Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101
[TBL] [Abstract][Full Text] [Related]
12. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
[TBL] [Abstract][Full Text] [Related]
13. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the wild type p73 gene in human bladder cancer.
Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
[TBL] [Abstract][Full Text] [Related]
16. P73 gene expression in ovarian cancer tissues and cell lines.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
[TBL] [Abstract][Full Text] [Related]
17. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
18. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
